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Acrylic cement pulmonary embolus masquerading
as an embolized central venous catheter fragment
Jason N. MacTaggart, MD, Iraklis I. Pipinos, MD, Jason M. Johanning, MD, and Thomas G. Lynch,
MD, Omaha, Neb
An acrylic cement pulmonary embolus is a rare complication of percutaneous vertebroplasty. Many patients remain
completely asymptomatic, but others may present with chest discomfort, dyspnea, and even cardiovascular collapse
leading to death. Here we present an asymptomatic patient initially thought to have a central venous catheter pulmonary
artery embolus based on the morphology of the foreign body on imaging exams. A more thorough investigation
established the diagnosis of an acrylic cement pulmonary embolus resulting from percutaneous vertebroplasty procedures
performed many months before the embolus discovery. The diagnostic work-up, treatment strategy, and a review of the
literature are presented. (J Vasc Surg 2006;43:180-3.)Foreign body pulmonary emboli are rare but well de-
scribed occurrences in the medical literature. Frequently
the result of fractured intravascular catheters, other less
frequent causes include dislodged radioactive implants,
missiles, and even a ureteral stent.1 Here we report an
asymptomatic acrylic cement pulmonary artery embolus
discovered months after percutaneous vertebroplasty.
CASE REPORT
A 65-year-old woman was referred for evaluation of a tubular
shaped, radiopaque, 11-cm foreign body in her right lung (Fig 1, a
and b). The patient had multiple myeloma and was being evaluated
for stem cell transplantation when, on a screening chest radio-
graph, she was noted to have an embolized central venous catheter
fragment. Computerized tomographic (CT) angiography of the
chest demonstrated the foreign body to be situated in the right
interlobar pulmonary artery, with one of its two ends extending
into the middle lobe lateral segmental artery and the other in the
lower lobe basal segmental artery (Fig 2). Upon further question-
ing, the patient denied any respiratory or chest symptoms. She also
denied having had any previous central venous catheters or any
other instrumentation of her central veins.
The patient was in good health until 4 months prior when she
presented with a pathologic left femoral neck fracture. The patient
underwent successful total hip arthroplasty. A bone biopsy speci-
men was consistent with multiple myeloma. Twomonths later, she
presented with excruciating back pain requiring large doses of oral
narcotic for relief. Magnetic resonance imaging demonstrated
pathologic fractures of thoracic vertebrae 9 and 11 and lumbar
vertebrae 3, 4, and 5.
To help alleviate her pain, she underwent two sessions of
percutaneous vertebroplasty. The procedure involves the introduc-
tion of a viscous mixture of polymethylmethacrylate (PMMA) and
barium into the fractured vertebral body under fluoroscopic guid-
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180ance. The thoracic lesions were repaired initially, and the lumbar
lesions were repaired 2 weeks later. There were no apparent
complications, and the patient experienced significant pain relief.
Two months after the vertebroplasties, she was referred for a
stem cell transplant. A screening chest film demonstrated the
foreign body in her right lung. After detailed inspection of the
chest film, it was determined that the characteristics of the foreign
body closely resembled the mixture of PMMA and barium used for
the vertebroplasty procedures. This same material was also identi-
fied within the paravertebral venous system adjacent to the frac-
tured vertebrae (Fig 1, c and d). Review of the patient’s films
obtained before the vertebroplasty procedures showed no foreign
bodies. From the patient’s history and radiologic findings, the
diagnosis of an acrylic cement pulmonary artery embolus was
made.
Because the patient was asymptomatic with no flow impair-
ment seen on CT pulmonary angiography, an initial treatment
course of observation was chosen. The patient then underwent
high-dose chemotherapy and a peripheral stem cell transplant for
her multiple myeloma.
On multiple follow-up visits, the patient denied experiencing
any respiratory or chest-related symptoms. Eighteen months after
the embolic event, a CT scan of the chest demonstrated the cement
embolus had not changed position. In addition, there was no
evidence of any associated thrombus within the pulmonary arter-
ies. Two years after the vertebroplasty procedures, the patient
remains without any symptoms referable to the cement embolus.
DISCUSSION
Percutaneous vertebroplasty was initially described in
1984 for the treatment of vertebral angiomata.2 Since then,
its use for the treatment of pain associated with neoplastic
or osteoporotic vertebral body fractures has increased. The
technique typically consists of injecting approximately 2 to
10 mL of a viscous mixture of PMMA and an opacifying
agent, such as barium, into the affected vertebral body
using 10- to 15-gauge needles. Visualization of the injec-
tion is usually provided by fluoroscopy or CT.2
Leakage of PMMA into the paraspinal veins is seen in
up to 39% of patients undergoing vertebroplasty for osteo-
porotic compression fractures.3 Technical factors thought
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inadequately polymerized cement and lack of visual guid-
ance during injection.4 Although leakage of PMMA into
the paraspinal veins is a common occurrence, the incidence
of pulmonary emboli is reported to range from 1%5 to
4.6%.6 On imaging studies, the appearances of such emboli
range from varying sizes of amorphous, multidimensional
masses to long, linear catheter-like shapes.7,8
The Table outlines the documented cases of pulmonary
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and infection must be balanced with the risks of removal.
With the advent and improvement of endovascular tech-
niques, it has become easier—and possibly safer—to re-
move these foreign bodies. Some advocate removal in all
instances,16 whereas others recommend a more selective
approach. Actis Dato et al17 reviewed their experience with
foreign bodies in the heart and pulmonary arteries and
Table 1. Reported cases of acrylic cement pulmonary emb
Year/Ref Patient(s) Primary Disease Symptoms
19999 41 y female Langerhans cell
vertebral
histiocytosis
Immediate chest 
delayed dyspne
hemoptysis
200110 3 patients Compression
fractures
Dyspnea and tran
pulmonary ede
in one patient,
others
asymptomatic
20024 60 y male Multiple
myeloma
Mild dyspnea
20024 57 y male Multiple
myeloma
Immediate dyspn
chest discomfo
20024 60 y female Multiple
myeloma
Asymptomatic
200211 75 y female Osteoporotic
compression
fractures
Patient under gen
anesthesia;
bradycardia,
hypotension,
hypocapnia
20027 55 y male Osteogenesis
imperfecta
Immediate
hypoxemia,
hypotension, a
atrial fibrillatio
200312 52 y female Compression
fracture
Immediate hot
flushes; delayed
mild dyspnea.
200313 67 y male Osteoporotic
fractures
Asymptomatic
200414 83 y female Osteoporotic
compression
fractures
Immediate
desaturation,
tachycardia,
hypertension
20048 68 y female Osteoporotic
compression
fractures
No immediate
symptoms; 24
hours later cou
fever, chest
discomfort; by
days ARDS
20046 3 patients Multiple
myeloma
Asymptomatic
200515 72y male Traumatic
compression
fractures
Asymptomatic;
discovered 2 ye
after procedure
ACLS, advanced cardiac life support. ARDS, adult respiratory distress syndfound that asymptomatic patients could be expectantlymanaged, experiencing no adverse effects for as long as 19
years. In another case report, an unretrieved guidewire
embolus was followed for 14 years without adverse ef-
fects.18
As there have been few long-term follow-up reports on
patients with PMMA pulmonary embolism, their definitive
management is unknown. In a description of the pulmo-
nary embolectomy specimens removed 48 hours after a
Treatment Follow-up Outcome
Supplemental O2,
anticoagulants
1 month Pulmonary infarction
(resolved on follow
up CT scan),
symptoms resolved
None described Unknown Symptoms resolved
Supplemental O2,
anticoagulants
Unknown Symptoms resolved
Supplemental O2,
anticoagulants
Unknown Symptoms resolved
Supplemental O2,
anticoagulants
Unknown Symptoms resolved
ACLS
resuscitation
Death
Anticoagulation
Pulmonary
embolectomy
under CBP 48
hours after
vertebroplasty
3 months Successful removal of
multiple thrombus
covered pieces of
acrylic
Anticoagulation
Percutaneous
capture, open
removal
6 months Successful removal,
uneventful recovery
Unknown Unknown Unknown
ACLS
resuscitation,
intubation
Death
Pulmonary
embolectomy
under CPB 10
days after
vertebroplasty
Death, 20 days after
vertebroplasty
Observation 5-11 months No adverse effects
Vena caval
cement
operatively
removed;
pulmonary
cement left in
place
2 years Successful removal,
uneventful recoveryoli.
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arsvertebroplasty, the cement fragments were found not to be
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layer of thrombus, despite anticoagulation.7 However, be-
cause the embolectomy was performed relatively early after
the embolic event, it is still unknown whether these cement
fragments would have incorporated into the vessel wall and
remained in a stable position over time. Two reports de-
scribe acrylic cement pulmonary emboli observed for as
long as 2 years without any adverse effects.6,15 In our
patient, the cement embolus has remained in stable posi-
tion and has been completely asymptomatic for 2 years.
CONCLUSION
Clinicians should be aware that pulmonary embolism of
PMMA may occur after percutaneous vertebroplasty, and
its radiographic appearance may mimic that of a catheter
embolus. Vascular surgeons, in particular, may be called
upon more frequently to evaluate and treat this condition as
more vertebroplasties are expected to be performed for
both benign and malignant vertebral body fractures.2 Pa-
tients may be completely asymptomatic, but may also
present with acute, severe, cardiovascular instability. Non-
operative therapy consisting of supportive care, with or
without anticoagulation, is an acceptable initial manage-
ment option in the asymptomatic patient.
The long-term consequences of PMMA lodged in the
pulmonary arterial system are unknown, but it appears to
have caused no adverse effects in our patient for a follow-up
period of 2 years. Based on the findings from our patient
and a review of the literature, we believe the operative or
endovascular removal of PMMA in asymptomatic patients
is unlikely to be necessary. Operative or endovascular re-
moval may be considered in patients with signs or symp-
toms secondary to the embolization and in asymptomatic
patients with sizable fragments that change positions on
imaging exams or appear to generate significant flow re-
striction in the pulmonary artery trunk, or the left and right
pulmonary arteries and their lobar branches.
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